Literature DB >> 19683261

Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.

Chadwick F Haarer1, Anuradha Gopalan, Satish K Tickoo, Peter T Scardino, James A Eastham, Victor E Reuter, Samson W Fine.   

Abstract

PURPOSE: We compared prostate cancer detected in transition zone directed needle biopsies with those in corresponding radical prostatectomy specimens.
MATERIALS AND METHODS: We reviewed needle biopsy and radical prostatectomy slides from 61 patients in whom cancer was present on transition zone directed needle biopsy. We assessed needle biopsy cancer features as well as transition zone lesions and dominant tumor sites on radical prostatectomy.
RESULTS: Prostate cancer was detected in 25 of 61 left (41%), 23 of 61 right (38%) and 13 of 61 bilateral (21%) transition zone directed needle biopsies. On radical prostatectomy 24 of 61 cases (39.5%) had no tumor in the transition zone, 24 of 61 (39.5%) had nondominant transition zone cancer and 13 of 61 (21%) had a dominant transition zone lesion. Of cases with cancer in the left and right transition zone directed needle biopsy 18 of 38 (47%) and 17 of 36 (47%), respectively, had no transition zone tumor or showed tumor in the contralateral transition zone only at radical prostatectomy. In 8 cases the transition zone directed core was the only one with cancer on needle biopsy and 2 of 8 (25%) such cases showed dominant transition zone cancer at radical prostatectomy.
CONCLUSIONS: Cancer identified in transition zone directed needle biopsy cores was not from the transition zone or did not reflect a dominant transition zone lesion in almost 80% of cases. Cancer identified in a left or right transition zone directed needle biopsy did not predict ipsilateral transition zone cancer in almost 50% of cases. These findings suggest that such biopsies do not adequately characterize transition zone tumors. Thus, care should be taken in their interpretation.

Entities:  

Mesh:

Year:  2009        PMID: 19683261     DOI: 10.1016/j.juro.2009.06.042

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: phase II multicenter clinical trial.

Authors:  Hiroji Uemura; Futoshi Sano; Akira Nomiya; Toshihiro Yamamoto; Masafumi Nakamura; Yasuhide Miyoshi; Kenta Miki; Kazumi Noguchi; Shin Egawa; Yukio Homma; Yoshinobu Kubota
Journal:  World J Urol       Date:  2012-02-04       Impact factor: 4.226

2.  Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Authors:  D M Somford; W Vreuls; T S Jansen; J P van Basten; H Vergunst
Journal:  World J Urol       Date:  2013-07-20       Impact factor: 4.226

Review 3.  Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Authors:  Marc A Bjurlin; H Ballentine Carter; Paul Schellhammer; Michael S Cookson; Leonard G Gomella; Dean Troyer; Thomas M Wheeler; Steven Schlossberg; David F Penson; Samir S Taneja
Journal:  J Urol       Date:  2013-02-26       Impact factor: 7.450

4.  TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.

Authors:  Anuradha Gopalan; Margaret A Leversha; Maria E Dudas; Alexandra C Maschino; Jeremy Chang; Hikmat A Al-Ahmadie; Ying-Bei Chen; Satish K Tickoo; Victor E Reuter; Samson W Fine
Journal:  Histopathology       Date:  2013-05-23       Impact factor: 5.087

Review 5.  Optimization of prostate biopsy: review of technique and complications.

Authors:  Marc A Bjurlin; James S Wysock; Samir S Taneja
Journal:  Urol Clin North Am       Date:  2014-05       Impact factor: 2.241

Review 6.  Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer.

Authors:  Seyed Saeid Dianat; H Ballentine Carter; Katarzyna J Macura
Journal:  Urol Oncol       Date:  2013-06-17       Impact factor: 3.498

7.  Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer.

Authors:  Darren J Katz; Rodrigo Pinochet; Kyle A Richards; Guilherme Godoy; Kazuma Udo; Lucas Nogueira; Angel M Cronin; Samson W Fine; Peter T Scardino; Jonathon A Coleman
Journal:  Prostate Cancer       Date:  2014-05-11

8.  Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway.

Authors:  Louise Dickinson; Hashim U Ahmed; Clare Allen; Jelle O Barentsz; Brendan Carey; Jurgen J Futterer; Stijn W Heijmink; Peter Hoskin; Alex P Kirkham; Anwar R Padhani; Ch M Raj Persad; Jan van der Meulen; Arnauld Villers; Mark Emberton
Journal:  Urol Oncol       Date:  2013-04       Impact factor: 3.498

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.